Press "Enter" to skip to content

Sun Pharma Q2 net loss at Rs 219 cr due to provisions for US antitrust case

The company had posted a net profit of Rs 912.12 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a BSE filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/sun-pharma-q2-net-loss-at-rs-219-cr-due-to-provisions-for-us-antitrust-case/66613365?utm_source=RSS&utm_medium=ETRSS

Also Read:   DoP lists options to rationalise drug trade margins for Niti Aayog